Modernising Subject Payments in Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-17.pdf
Continue Reading →
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
Clinical Research v3i3
Managing the Use of Research- Grade Kits During Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-16.pdf
Continue Reading →
Clinical Research v3i3
Feasibility, Risk Management and Clinical Trials – Art or Science?
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-15.pdf
Continue Reading →
Clinical Research v3i3
Optimising Clinical Research Site Performance through Additive Patient Enrolment
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-14.pdf
Continue Reading →
Clinical Research v3i3
Business Partnering – The Way Forward for Cryogenics
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-13.pdf
Continue Reading →
Clinical Research v3i3
Determination of Efficacy of AnvirzelTM in 37 Established Cancer Cell Lines
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-12.pdf
Continue Reading →
